» Articles » PMID: 10080529

Functions of Bruton's Tyrosine Kinase in Mast and B Cells

Overview
Journal J Leukoc Biol
Date 1999 Mar 18
PMID 10080529
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Bruton's tyrosine kinase (Btk) plays crucial roles in B cell differentiation as well as mast cell activation through the high-affinity IgE receptor (FcepsilonRI). Defects in the btk gene lead to agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Mast cells from xid and btk null mice exhibit mild defects in degranulation and severe impairments in the production of proinflammatory cytokines upon FcepsilonRI cross-linking. Recent studies demonstrated the role of Btk in a sustained increase in intracellular calcium concentrations in response to antigen receptor stimulation. Btk is also involved in the activation of stress-activated protein kinases, JNK/SAPK1/2, and thereby regulates c-Jun and other transcription factors that are important in cytokine gene activation. Regulation of the JNK/SAPK activation pathway by Btk may be related to the proapoptotic function of Btk in the programmed cell death in these hematopoietic cells.

Citing Articles

Synthesis of Radiopharmaceuticals "In-Loop" C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase.

Donnelly D, Preshlock S, Kaur T, Tran T, Wilson T, Mhanna K Front Nucl Med. 2024; 1:820235.

PMID: 39355640 PMC: 11440948. DOI: 10.3389/fnume.2021.820235.


Nerve Growth Factor and Autoimmune Diseases.

Terracina S, Ferraguti G, Tarani L, Fanfarillo F, Tirassa P, Ralli M Curr Issues Mol Biol. 2023; 45(11):8950-8973.

PMID: 37998739 PMC: 10670231. DOI: 10.3390/cimb45110562.


Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.

Park H, Chae M, Ko J, Kikkawa D, Jang S, Yoon J PLoS One. 2022; 17(12):e0279060.

PMID: 36521376 PMC: 9754806. DOI: 10.1371/journal.pone.0279060.


Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis.

Carnero Contentti E, Correale J Drug Des Devel Ther. 2022; 16:3473-3490.

PMID: 36238195 PMC: 9553159. DOI: 10.2147/DDDT.S348129.


Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling.

Kokabee M, Wang X, Voorand E, Alin E, Kokabee L, Khan F Cancer Genomics Proteomics. 2022; 19(4):415-427.

PMID: 35732327 PMC: 9247882. DOI: 10.21873/cgp.20329.